Company Valuation: TELCON RF PHARMACEUTICAL. Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 5,17,387 2,55,964 1,10,233 97,672 70,587 62,827
Change - -50.53% -56.93% -11.39% -27.73% -10.99%
Enterprise Value (EV) 1 5,80,973 2,88,705 1,30,775 1,14,577 1,16,241 64,971
Change - -50.31% -54.7% -12.39% 1.45% -44.11%
P/E -12x -11.1x -2.56x 8.52x -2.64x -3.84x
PBR 5.81x 2.74x 1.31x 0.97x 0.85x 0.58x
PEG - 0.2x -0.1x -0x 0x 0.1x
Capitalization / Revenue 15.6x 6.76x 3.96x 2.69x 1.86x 1.46x
EV / Revenue 17.5x 7.63x 4.7x 3.16x 3.07x 1.51x
EV / EBITDA 252x -795x 599x 22x 26.2x 11.7x
EV / EBIT -278x -63.3x -32.2x 119x -1,648x 90.4x
EV / FCF -562x -37.4x 414x -21.5x 11.2x -7.31x
FCF Yield -0.18% -2.67% 0.24% -4.64% 8.9% -13.7%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -16,772 -8,764 -13,233 3,417 -7,417 -2,390
Distribution rate - - - - - -
Net sales 1 33,141 37,841 27,830 36,307 37,865 43,162
EBITDA 1 2,307 -363.1 218.5 5,210 4,436 5,543
EBIT 1 -2,090 -4,563 -4,063 965.3 -70.55 718.6
Net income 1 -40,893 -23,098 -42,084 13,906 -26,320 -11,456
Net Debt 1 63,586 32,741 20,542 16,904 45,654 2,143
Reference price 2 2,02,000.00 97,500.00 33,833.33 29,100.00 19,566.67 9,170.00
Nbr of stocks (in thousands) 2,561 2,625 3,258 3,356 3,608 6,851
Announcement Date 22/03/21 22/03/22 21/03/23 19/03/24 18/03/25 19/03/26
1KRW in Million2KRW
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 86.98L
26.87x6.02x15.59x1.54% 43TCr
48.94x17.35x34.79x-.--% 24TCr
16.02x0.64x11.64x2.83% 14TCr
20.59x6.43x15.51x0.6% 11TCr
34.98x6.78x19.65x1% 8TCr
42.3x12.69x28.34x-.--% 8.28TCr
26.95x6.17x21.74x1.52% 5.25TCr
45.19x2.09x13.21x1.84% 5.18TCr
62.62x8.09x35.83x-.--% 5.15TCr
Average 36.05x 7.36x 21.81x 1.04% 12.46TCr
Weighted average by Cap. 33.01x 8.00x 20.86x 1.13%

Y-o-Y evolution of P/E

Valuation ratios - P/E - TELCON RF PHARMACEUTICAL. Inc.

Historical PBR trend

Valuation ratios - PBR - TELCON RF PHARMACEUTICAL. Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - TELCON RF PHARMACEUTICAL. Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - TELCON RF PHARMACEUTICAL. Inc.

  1. Stock Market
  2. Stocks
  3. A200230 Stock
  4. Valuation TELCON RF PHARMACEUTICAL. Inc.